Grants per year
Personal profile
Research Interests
Inflammatory bowel disease (Crohn's disease and ulcerative colitis), therapeutic drug monitoring, clinical trials
Training Experience
2011 | Residency, Boston University Medical Center |
2014 | Fellowship, University of Chicago |
2015 | Fellowship, Northwestern University, Feinberg School of Medicine |
Education/Academic qualification
MD, Federal University of Ceara
… → 2006
Medicine, MD, Federal University of Ceara, Brazil
… → 2006
Research interests
- Inflammatory Bowel Disease
Fingerprint
Dive into the research topics where Emanuelle Araujo Lima Bellaguarda is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants
-
Protocol M14-234: A Multicenter, Randomized, Double-Blind, Placebo -Controlled Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis
Bellaguarda, E. A. L. & Hanauer, S. B.
7/23/19 → 7/23/22
Project: Research project
Research Output
-
Checkpoint Inhibitor-Induced Colitis
Bellaguarda, E. & Hanauer, S., Feb 1 2020, In: The American journal of gastroenterology. 115, 2, p. 202-210 9 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Disordered Eating, Body Dissatisfaction, and Psychological Distress in Patients with Inflammatory Bowel Disease (IBD)
Wabich, J., Bellaguarda, E., Joyce, C., Keefer, L. & Kinsinger, S., Jun 1 2020, In: Journal of Clinical Psychology in Medical Settings. 27, 2, p. 310-317 8 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Recurrent brisk haematochezia in a patient with quiescent Crohn's disease
Gasanova, Z., Lemmer, A. & Bellaguarda, E., Jan 1 2020, (Accepted/In press) In: Frontline Gastroenterology. flgastro-2019-101404.Research output: Contribution to journal › Article › peer-review
-
Epidemiology and implications of concurrent diagnosis of eosinophilic oesophagitis and IBD based on a prospective population-based analysis
Limketkai, B. N., Shah, S. C., Hirano, I., Bellaguarda, E. & Colombel, J. F., Dec 1 2019, In: Gut. 68, 12, p. 2152-2160 9 p.Research output: Contribution to journal › Article › peer-review
11 Scopus citations -
Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease
Christensen, B., Micic, D., Gibson, P. R., Yarur, A., Bellaguarda, E., Corsello, P., Gaetano, J. N., Kinnucan, J., Rao, V. L., Reddy, S., Singh, S., Pekow, J. & Rubin, D. T., Mar 2018, In: Alimentary Pharmacology and Therapeutics. 47, 6, p. 753-762 10 p.Research output: Contribution to journal › Article › peer-review
32 Scopus citations